Phosphinatophenylporphyrins tailored for high photodynamic efficacy
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
30259016
DOI
10.1039/c8ob01984c
Knihovny.cz E-zdroje
- MeSH
- fotochemoterapie * MeSH
- fotosenzibilizující látky chemie metabolismus farmakologie MeSH
- HeLa buňky MeSH
- lidé MeSH
- lidský sérový albumin metabolismus MeSH
- porfyriny chemie metabolismus farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- fotosenzibilizující látky MeSH
- lidský sérový albumin MeSH
- porfyriny MeSH
The development of effective photosensitizers is particularly attractive for photodynamic therapy of cancer. Three novel porphyrin photosensitizers functionalized with phosphinic groups were synthesized and their physicochemical, photophysical, and photobiological properties were collected. Phosphinic acid groups (R1R2POOH) attached to the porphyrin moiety (R1) contain different R2 substituents (methyl, isopropyl, phenyl in this study). The presence of phosphinic groups does not influence absorption and photophysical properties of the porphyrin units, including the O2(1Δg) productivity. In vitro studies show that these porphyrins accumulate in cancer cells, are inherently nontoxic, however, exhibit high phototoxicity upon irradiation with visible light with their phototoxic efficacy tuned by R2 substituents on the phosphorus centre. Thus, phosphinatophenylporphyrin with isopropyl substituents has the strongest photodynamic efficacy due to the most efficient cellular uptake. We demonstrate that these porphyrins are attractive candidates for photodynamic applications since their photodynamic efficacy can be easily tuned by the R2 substituent.
Citace poskytuje Crossref.org
The nanoscaled metal-organic framework ICR-2 as a carrier of porphyrins for photodynamic therapy